Cardiva, a manufacturer and distributor of medical products, has entered into a partnership to distribute Johnson&Johnson MedTech’s spine surgery products in Spain for five years. The agreement includes the national marketing of DePuy Synthes’ Spine range.With this partnership, Cardiva aims to provide materials to simplify and make spinal surgical interventions less invasive, thus enabling predictable, reproducible, and optimal outcomes.
The Spanish company prides itself on its logistical platform with storage facilities, thermo-disinfection capabilities, and inventory management. Through this collaboration, Cardiva reaffirms its commitment to effectively meet the needs of healthcare professionals, advancing patient care while delivering clinical and economic value to the healthcare system.
This partnership with Johnson&Johnson comes a year and a half after Cardiva launched a new traumatology division, aiming to address a wide range of needs from reconstructive surgery, osteosynthesis, regenerative medicine, spinal products, infection-focused products, to custom-made or tumor prostheses.
About Cardiva
Established in 1989, Cardiva currently exports approximately 30% of its production outside of Spain, with Italy being one of its primary markets where it also operates a factory. The company has a team of over 150 professionals.Cardiva projects a 17% profit increase for the fiscal year 2023, reaching €14 million. In traumatology, Cardiva aims to achieve a 15% market share in Spain in its first full year of operation.